Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

Clinical trial NCT00401219 · COMPLETED

Trial details

NCT number: NCT00401219
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Estrogen Replacement Therapy

Start date: 2006-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.